Fundamentals Hub
▼ FY 2025 Summary Analysis
Annual report ending Dec 31, 2025Overview and Growth
In fiscal 2025, GILEAD SCIENCES, INC. recorded $29.44B of revenue, net income of $8.51B, and an operating cash inflow of $10.02B. Revenue of $29.44B sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line expanded 2.4% from $28.75B in fiscal 2024, increasing the company’s operating scale. Diluted earnings per share were $6.78, translating the period’s attributable earnings into the amount reported for each diluted share. Asset turnover was 0.5x, relating the company’s annual revenue directly to the total assets reported at the period end.Profitability
The first profit layer was $23.21B of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 78.8%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced $10.02B of income after the reported operating expense base, before the remaining non-operating and tax effects. Operating margin measured 34.0%, showing the portion of revenue preserved after the full set of operating costs. Net income came to $8.51B, completing the progression from revenue through gross and operating profitability to the final reported result. Measured against reported revenue, net income produced a 28.9% margin after operating costs and the remaining recognized items. The earnings statement records $9.80B of pretax income, the profit base against which the reported tax provision can be assessed. Measured against revenue, pretax income equaled 33.3%, adding a pre-tax profitability layer between revenue and net income. The reported income-tax provision was $1.29B, the amount recognized between pretax income and the final net-income result. Relative to pretax income, the tax provision measured 13.1%, quantifying the portion of pre-tax earnings paid in income tax.Liquidity and Capital Structure
The company held $59.02B of assets against $36.41B of liabilities and $22.62B of equity, revealing how the asset base was financed. At period end, current assets of $18.34B compared with current liabilities of $11.81B, defining the company’s short-term resource position. The current ratio was 1.55x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $7.56B, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 64.0% of current liabilities, showing how much near-term coverage came from cash alone. Borrowings totaled $24.94B, adding a fixed financing obligation alongside the company’s equity capital. Debt equaled 1.1x of book equity, describing the relative scale of borrowing and shareholder capital. Debt represented 42.2% of total assets, placing borrowing in the context of the company’s full resource base. Liabilities represented 61.7% of total assets, quantifying the liability-funded share of the company’s resource base. Cash and equivalents equaled 12.8% of total assets, showing the liquid cash component within the company’s broader resource base.Cash Flow and Earnings Quality
Cash flow from operations was $10.02B, a reported cash inflow that can be compared directly with net income and capital spending. The operating-cash-flow-to-net-income relationship was 1.18x, comparing cash generated by operations with the bottom-line earnings result. The cash-flow statement records $563.00M of capital expenditures, the investment amount considered after operating cash generation. Capital expenditures represented 5.6% of operating cash flow, leaving the remainder available as free cash flow. The combination of operating cash flow and capital spending produced $9.46B of positive free cash flow for the period. Free cash flow represented 32.1% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 16.0% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025.
Analysis generated .